CHU de Bordeaux, Hôpital Pellegrin, Service d'oto-rhino-laryngologie, de chirurgie cervico-faciale et d'ORL pédiatrique
Bordeaux, 33076, France
Location contact
Thomas SAGARDOY, MD
CONTACT
NCT Number: NCT06559293
Nasofibroscopy is the gold standard for laryngeal pathology diagnosis. However, this examination is invasive and can be poorly tolerated in the pediatric population. Laryngeal ultrasound appears to be a better tolerated alternative. However, few data exist in the pediatric population in the literature. The aim of this study is to evaluate the feasibility of laryngeal ultrasound in a larger pediatric population of pathological and non-pathological subjects.
Trial opening soon.
Get Notified0 year–15 year
All sexes
Observational
Bordeaux, 33076, France
Thomas SAGARDOY, MD
CONTACT
According to current knowledge, the gold standard for diagnosing laryngeal pathologies is flexible fiberoptic laryngoscopy (FFL), as it allows visualisation of the motricity of the laryngeal structures and the appearance of the mucous membranes. However, this is an invasive examination, which can be poorly tolerated in the pediatric population. This poor tolerance can make it difficult to obtain an accurate diagnosis because of the child's movements. With the aim of improving patient comfort without compromising diagnostic performance, some studies describe laryngeal ultrasound (LUS) as an alternative to FFL. This imaging examination appears to be better tolerated than FFL because it is less invasive for the patient. However, there are few data available in the infant population. The main limitations of LUS are obtaining a satisfactory ultrasound window and inter-rater reproducibility. For these reasons, the aim of this study is to assess the feasibility of LUS in the pediatric population and to obtain reference frame enabling the different laryngeal structures to be visualised. We will include around one hundred patients treated in the pediatric ENT unit, with or without laryngeal pathology. An ultrasound record will be performed during the consultation in addition to the usual examination. The record will be analysed by a blinded assessor. A single consultation will be required and no follow-up is planned.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
laryngeal ultrasound with linear probe will be positioned on the patient's neck. A list of anatomical sites to be visualised will be determined beforehand. Once all the pre-determined structures have been visualised, in an axial and sagittal plane, we will note the position of the ultrasound probe and its orientation. This will enable us to determine the ideal position of the ultrasound probe for obtaining all the elements of interest on a section that will be called the reference section.
Time frame: At Baseline (D0)
Define detailed and reproducible ultrasound images using consistent anatomical landmarks for diagnostic assessment of the larynx
Time frame: At Baseline (D0)
We will evaluate the demographic characteristics that may affect the reproducibility of ultrasound images
Contact information is provided by the study sponsor or research team.
University Hospital, Bordeaux
Other
Pilot Feasibility Study of Laryngeal Ultrasound in the Paediatric Population
Acronym: ECHO-LARYNX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07639398
Airway Management, Laryngeal Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04575142
Laryngeal Diseases, Otorhinolaryngologic Diseases
New York, United States
View Trial DetailsNCT02960243
Action Tremor, Central Nervous System Diseases
Vancouver, British Columbia, Canada
View Trial DetailsNCT01276418
Laryngeal Diseases, Otorhinolaryngologic Diseases
Yvoir, Belgium
View Trial Details